Ergoteles LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 305 filers reported holding NOVOCURE LTD in Q3 2022. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2022$1,276,000
-75.6%
16,798
-28.7%
0.04%
-62.5%
Q2 2021$5,223,000
-0.7%
23,548
-22.5%
0.12%
-31.0%
Q4 2020$5,260,000
+376.0%
30,400
+206.3%
0.17%
+19.2%
Q3 2020$1,105,0009,9250.15%
Other shareholders
NOVOCURE LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Nordwand Advisors, LLC 1,515,000$111,125,24913.86%
Invus Financial Advisors, LLC 350,884$25,737,34113.70%
HARTLINE INVESTMENT CORP/ 304,482$22,333,7555.08%
GREAT POINT PARTNERS LLC 241,000$17,677,3503.46%
Tri Locum Partners LP 72,400$5,311,0002.15%
Taylor Frigon Capital Management LLC 42,061$3,085,1741.75%
HighVista Strategies LLC 28,007$2,054,3131.22%
HAP Trading, LLC 124,500$10,2941.05%
Private Harbour Investment Management & Counsel, LLC 12,285$901,1050.99%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 32,000$2,344,0000.72%
View complete list of NOVOCURE LTD shareholders